Background. CDRI 97/78 has shown efficacy in animal models of falciparum malaria. The present study is the first in‐human phase I trial in healthy volunteers. Methods. The study was conducted in 50 healthy volunteers in a single, ascending dose, randomized, placebo‐controlled, double blind design.
N. Shafiq +15 more
wiley +1 more source
Single dose pharmacokinetics study of 97/63 (IND191710, 2004), a trioxane antimalarial developed by Central Drug Research Institute, Lucknow, India, was studied in rats following intravenous and oral administration. Serum samples were analysed by HPLC‐UV assay.
Hari Narayan Kushwaha +4 more
wiley +1 more source
Mechanistic Evaluation of the Stability of Arylvinyl-1,2,4-trioxanes under Acidic Conditions for Their Oral Administration as an Antimalarial Drug. [PDF]
Kumari A +8 more
europepmc +1 more source
Lewis Acids and Heteropoly Acids in the Synthesis of Organic Peroxides. [PDF]
Yaremenko IA +5 more
europepmc +1 more source
Design, molecular docking, drug-likeness, and molecular dynamics studies of 1,2,4-trioxane derivatives as novel Plasmodium falciparum falcipain-2 (FP-2) inhibitors. [PDF]
Ghosh S, Chetia D, Gogoi N, Rudrapal M.
europepmc +1 more source
1,2,4-Trioxolane and 1,2,4,5-Tetraoxane Endoperoxides against Old-World Leishmania Parasites: In Vitro Activity and Mode of Action. [PDF]
Mendes A +6 more
europepmc +1 more source
Synthesis and antimalarial activity of 3,3-spiroanellated 5,6-disubstituted 1,2,4-trioxanes. [PDF]
Maurya R +10 more
europepmc +1 more source
Application of BF3·Et2O in the synthesis of cyclic organic peroxides (microreview). [PDF]
Radulov PS, Yaremenko IA.
europepmc +1 more source
Effects of Albumin-Chlorogenic Acid Nanoparticles on Apoptosis and PI3K/Akt/mTOR Pathway Inhibitory Activity in MDA-MB-435s Cells. [PDF]
Alzahrani B +9 more
europepmc +1 more source
Preparation of bicyclic 1,2,4-trioxanes from gamma,delta-unsaturated ketones. [PDF]
Ramirez AP, Thomas AM, Woerpel KA.
europepmc +1 more source

